Healthcare lobbying focus Positioned as a specialized government relations firm serving the healthcare sector with expertise in product approval, coverage and reimbursement, marketing practices, and implementation of public law. This suggests sales opportunities with healthcare technology providers, medical devices, pharmaceuticals, and biotechnology companies seeking federal influence.

Federal policy access Strong emphasis on Capitol Hill engagement and relationships with U.S. federal agencies such as HHS, Commerce, DHS, and DoD, indicating potential value for clients navigating regulatory pathways, funding programs, and healthcare policy shifts.

Experience and scale Small to mid-sized team (11-50 employees) with a track record since 1998 and a portfolio of over 60 healthcare clients, implying agility and a deep, targeted network that can rapidly mobilize for client-specific federal initiatives.

Policy expertise breadth Capabilities across life sciences topics including medical devices, pharmaceuticals, biotechnology, provider services, and biodefense, opening cross-sell opportunities to firms spanning multiple healthcare subsectors and regulatory needs.

Revenue opportunity Current revenue range indicates a mid-market positioning with potential to scale services for larger healthcare clients or multi-client campaigns, suggesting upsell opportunities around broader lobbying programs, strategic advisory, and comprehensive regulatory affairs management.